Skip to Main Content

Paper Details

Effect of <i>CYP3A4</i>*22 and <i>PPAR-α</i> Genetic Variants on Platelet Reactivity in Patients Treated with Clopidogrel and Lipid-Lowering Drugs Undergoing Elective Percutaneous Coronary Intervention.
Genes (Basel)
2
2020
A208G, CYP3A4, CYP3A4*22, CYP3A4*22/*22, Clopidogrel, G209A, P2Y12, PPAR, PPAR-, PPAR- (G209A, PPAR- (G209A and A208G), PPAR- A208G, PPAR- G209A, PPAR- Genetic Variants, PPAR- genetic variants, PPAR-a, Patients, Platelet, clopidogrel, fibrate, genetic variants, p = 0, patients, platelet, statin
Author NameAffiliation
Shefali S VermaCenter for Translational Bioinformatics, Institute for Biomedical Informatics, University of Pennsylvania
Marylyn D RitchieStanford University
Marylyn D RitchieStanford University
Li GongStanford University
Teri E KleinStanford University
Anthonius de BoerUtrecht Institute for Pharmaceutical Sciences, Utrecht University
Olaf H KlungelUtrecht Institute for Pharmaceutical Sciences, Utrecht University
Vera H M DeneerUtrecht Institute for Pharmaceutical Sciences, Utrecht University
Vera H M DeneerUniversity Medical Center Utrecht
  • 1 - 9

Datasets

Release 1.2